- Home
- HOLO vs ALGS Comparison
HOLO vs ALGS Comparison
Compare HOLO & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- ALGS
- Stock Information
- Founded
- HOLO 2018
- ALGS 2018
- Country
- HOLO China
- ALGS United States
- Employees
- HOLO N/A
- ALGS N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- HOLO Technology
- ALGS Health Care
- Exchange
- HOLO Nasdaq
- ALGS Nasdaq
- Market Cap
- HOLO 66.4M
- ALGS 64.8M
- IPO Year
- HOLO N/A
- ALGS 2020
- Fundamental
- Price
- HOLO $3.64
- ALGS $6.92
- Analyst Decision
- HOLO
- ALGS Strong Buy
- Analyst Count
- HOLO 0
- ALGS 2
- Target Price
- HOLO N/A
- ALGS $60.00
- AVG Volume (30 Days)
- HOLO 1.1M
- ALGS 98.5K
- Earning Date
- HOLO 01-01-0001
- ALGS 11-06-2025
- Dividend Yield
- HOLO N/A
- ALGS N/A
- EPS Growth
- HOLO N/A
- ALGS N/A
- EPS
- HOLO 13.81
- ALGS N/A
- Revenue
- HOLO $44,840,587.00
- ALGS $3,174,000.00
- Revenue This Year
- HOLO N/A
- ALGS N/A
- Revenue Next Year
- HOLO N/A
- ALGS N/A
- P/E Ratio
- HOLO $0.29
- ALGS N/A
- Revenue Growth
- HOLO 37.10
- ALGS N/A
- 52 Week Low
- HOLO $3.46
- ALGS $3.76
- 52 Week High
- HOLO $370.00
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- HOLO 35.24
- ALGS 27.43
- Support Level
- HOLO $3.83
- ALGS $9.25
- Resistance Level
- HOLO $4.54
- ALGS $8.76
- Average True Range (ATR)
- HOLO 0.33
- ALGS 0.75
- MACD
- HOLO -0.06
- ALGS -0.30
- Stochastic Oscillator
- HOLO 10.53
- ALGS 16.50
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.